SMAD3 and squamous cell lung carcinoma: Analysis using the UALCAN (Fig. 3A, B) and DNMIVD databases (Fig. 3C, D) showed significantly lower DNA methylation levels of the SMAD3 promoter region in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) tissues compared to normal tissues.